BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Drug Development

  Mateon Therapeutics Announces Updated Data from Fifth Cohort of Phase Ib Study of OXi4503 in Acute Myeloid Leukemia

  Mateon previously reported that two of four patients in this cohort of the study had morphological complete remissions following one cycle of treatment with OXi4503.

  October 30, 2017

   · 

  5 min read
• Policy

  Marrone Bio Innovations Receives EPA Approval for Novel Biofungicide

  Stargus is proven highly effective for controlling downy mildews and white molds.

  October 30, 2017

   · 

  5 min read
• Business

  Marrone Bio Innovations to Report Third Quarter 2017 Financial Results and Host a Conference Call on Monday, November 13th at 1:30 p.m. Pacific Time

  Management will host an investor conference call the same day to discuss the results, provide a corporate update, and conclude with a Q&A from participants.

  October 30, 2017

   · 

  3 min read
• Drug Development

  New Preclinical Data Suggest That Cellectar Biosciences’ PDC Platform Provides Enhanced Outcomes in Combination With External Radiation

  Investigators observed that CLR 127 was taken up and retained in the tumor cells at 6-10 fold higher level than normal tissue and sensitized the tumor cells to external radiation.

  October 30, 2017

   · 

  4 min read
• MiMedx CEO Replies to Fraudulent Information About the Company

  MiMedx announced today that the Company’s Chairman and CEO, Parker H. “Pete” Petit, has replied directly to shortseller Marc Cohodes’ letter to Mr. Petit dated October 27, 2017.

  October 30, 2017

   · 

  2 min read
• Business

  Minerva Neurosciences to Report Third Quarter 2017 Financial Results and Business Updates on November 6, 2017

  Management will host a webcast and conference call that day at 8:30 a.m. ET to discuss these results and updates.

  October 30, 2017

   · 

  1 min read
• BioMidwest

  Entellus Announces Long-Term Data Confirming the Durable Relief of Nasal Obstruction Symptoms With Latera From Spirox

  The 18 and 24-month data reinforces clinical benefits without cosmetic downside.

  October 30, 2017

   · 

  3 min read
• Business

  Ultragenyx to Host Conference Call for Third Quarter 2017 Financial Results and Corporate Update

  The company will host a conference call on Nov. 2, 2017 at 5pm ET to discuss third quarter 2017 financial results and provide a corporate update.

  October 30, 2017

   · 

  1 min read
• Drug Development

  FDA Approves BriaCell’s Roll-Over Combination Study with Checkpoint Inhibitor Immunotherapies to Allow Continued Access to BriaVax in Patients With Advanced Breast Cancer

  The study allows the patients who did not respond to BriaVax to be treated in combination with either pembrolizumab or ipilimumab.

  October 30, 2017

   · 

  6 min read
• Biotech Bay

  Vascular Dynamics Interim Data on MobiusHD Presented at TCT Conference Shows Significant Reductions in Ambulatory Systolic Blood Pressure At Six Months

  The company has Initiated Pivotal Trial for the MobiusHD in the US and EU

  October 30, 2017

   · 

  4 min read